Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897741 · ClinicalTrials.gov registry record
Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer
A clinical trial, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- 10
- Enrollment target
NCT00897741 is a clinical trial that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 10 participants.
The verdict
NCT00897741 has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study uses gene expression profiling to compare primary tumor cells with metastatic tumor cells in patients with metastatic pancreatic cancer.
Interventions
- GENETIC microarray analysis
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897741
The ClinicalTrials.gov registry entry for NCT00897741 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00897741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897741 about?
NCT00897741 is a clinical study titled "Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer". RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study uses gene expression profiling to compare primary tumor cells with metast...
What is the current status of trial NCT00897741?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2004-12. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00897741?
The interventions under investigation include: microarray analysis (GENETIC), laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00897741?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.